In terms of prognosis, individuals with SCLC who had high CDKN2A expression had substantially shorter overall survival times than those who had low CDKN2A expression (p < 0.05, Fig. 2D), indicating that CDKN2A might be an important prognostic indicator of SCLC patients. This evidence concerns the gene CDKN2A and small cell lung carcinoma.